ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476,927 | -8.8% | 17,027 | +1.9% | 0.01% | -14.3% |
| Q2 2023 | $522,867 | +80.9% | 16,705 | +62.9% | 0.01% | +75.0% |
| Q1 2023 | $289,004 | +8.8% | 10,252 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $265,585 | +22.4% | 10,164 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $217,000 | -19.3% | 9,737 | +7.9% | 0.00% | -20.0% |
| Q2 2022 | $269,000 | +30.6% | 9,026 | +15.3% | 0.01% | +66.7% |
| Q1 2022 | $206,000 | -18.6% | 7,828 | -4.7% | 0.00% | -40.0% |
| Q3 2021 | $253,000 | +14.5% | 8,217 | -8.8% | 0.01% | +25.0% |
| Q2 2021 | $221,000 | – | 9,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |